XXII
22nd Century GroupXXII
XXII
About: 22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Employees: 56
0
Funds holding %
of 7,316 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
22% more capital invested
Capital invested by funds: $299K [Q4 2024] → $364K (+$64.6K) [Q1 2025]
10% more funds holding
Funds holding: 31 [Q4 2024] → 34 (+3) [Q1 2025]
0.42% more ownership
Funds ownership: 10.25% [Q4 2024] → 10.66% (+0.42%) [Q1 2025]
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Research analyst outlook
We haven’t received any recent analyst ratings for XXII.
Financial journalist opinion
Based on 4 articles about XXII published over the past 30 days
Neutral
GlobeNewsWire
5 days ago
22nd Century Provides Corporate Update On Its VLN® MRTP Renewal Process – The First and Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less
Extensive Clinical Data Continues to Demonstrate VLN ® Reduced Nicotine Content Tobacco Helps Reduce Smoking and Increase Quit Attempts Growing List of VLN ® Based Cigarette Brands Bring Non-Addictive Alternatives to the Fight Against Smoking MOCKSVILLE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction today announces a corporate update regarding its Modified Risk Tobacco Product renewal process for its innovative VLN® reduced nicotine content products - the first and only combustible cigarette authorized by the U.S. Food and Drug Administration specifically to reduce the health harms of smoking.
Neutral
GlobeNewsWire
2 weeks ago
22nd Century Announces Operation 100 – A 100mm VLN® Cigarette Designed to Reach Even More Adult Smokers Who Want to Reduce Their Nicotine Consumption
100mm Cigarettes Comprise Approximately Half the U.S. Market, Giving Even More Smokers a Familiar Choice as They Seek Ways to Change Their Smoking Behavior First FDA Submission Planned for Q4 2025 MOCKSVILLE, N.C.,, June 26, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced the advancement of a 100mm VLN® reduced nicotine content cigarette.
Neutral
GlobeNewsWire
3 weeks ago
22nd Century Announces Second Partner VLN Product Deal as Part of Major Pinnacle Brand Expansion Agreement with Top-5 C-Store Chain
Launching New Pinnacle VLN and Moist Snuff Products in More Than 1,700 Stores Across 27 States MOCKSVILLE, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that is leading the fight against nicotine by offering smokers a choice about their nicotine consumption, today announced major updates to its Pinnacle product manufacturing and marketing agreement with its top-5 c-store chain customer, including the launch of four new Pinnacle SKUs, including two in the low nicotine product category.
Positive
Benzinga
3 weeks ago
Top 3 Risk Off Stocks That Could Blast Off This Month
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Neutral
Newsfile Corp
1 month ago
Emerging Growth Research Releases Q1 2025 Update Report on 22nd Century Group
New York, New York--(Newsfile Corp. - May 21, 2025) - Emerging Growth Research today released its latest quarterly update report on 22nd Century Group, Inc. (NASDAQ: XXII), following the Company's Q1 2025 results. The report reflects the continued operational progress made under new management and the outlook for meaningful financial improvement in 2025.
Neutral
GlobeNewsWire
1 month ago
22nd Century to Present at the Emerging Growth Conference on May 21, 2025
MOCKSVILLE, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) is pleased to announce that Larry Firestone, Chief Executive Officer, will present a brief corporate update at the Emerging Growth Conference on Wednesday, May 21, 2025, at 12:00 pm Eastern Time.
Neutral
Seeking Alpha
2 months ago
22nd Century Group, Inc. (XXII) Q1 2025 Earnings Call Transcript
22nd Century Group, Inc. (NASDAQ:XXII ) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants Matt Kreps - IR Larry Firestone - CEO Dan Otto - CFO Conference Call Participants Andrew White - Emerging Growth Research Operator Welcome to 22nd Century Group's First Quarter 2025 Conference Call and Webcast. At this time, all participants have been placed in a listen-only mode.
Neutral
GlobeNewsWire
2 months ago
22nd Century Group Reports First Quarter 2025 Financial Results
Sales Increase Approximately 50% Sequentially as 2025 Growth Strategy Drives New Sales Activity with Both Internal and External Brand Assets Across Multiple Categories
Neutral
GlobeNewsWire
2 months ago
22nd Century Group Completes Sale of Needle Rock Farms Assets
Further Strengthens Balance Sheet Cash Position MOCKSVILLE, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced closing of the sale of its Needle Rock Farms assets with net proceeds of approximately $770,000 after expenses.
Neutral
GlobeNewsWire
2 months ago
22nd Century Group Further Reduces Debt by $1.0 Million Following Financing Transaction
Year to Date Total Debt Reduction of approximately $3.8 Million MOCKSVILLE, N.C., May 07, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced that has repaid an additional $1 million in debt to its senior lender.
Charts implemented using Lightweight Charts™